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Poninvasive Assessment of Coronary
asodilation Using Magnetic Resonance Angiography
asahiro Terashima, MD, PHD,* Craig H. Meyer, PHD,† Brian G. Keeffe, MD,* Eric J. Putz, MD,*
rasmo de la Pena-Almaguer, MD,* Phillip C. Yang, MD,* Bob S. Hu, MD,*†
wight G. Nishimura, PHD,† Michael V. McConnell, MD, MSEE*†
tanford, California
OBJECTIVES The purpose of this study was to investigate the use of coronary magnetic resonance
angiography (MRA) for assessing human epicardial coronary artery vasodilation.
BACKGROUND Coronary vasodilation plays a vital role in the human coronary circulation. Previous studies of
epicardial coronary vasodilation have used invasive coronary angiography. Coronary MRA
may provide an alternative noninvasive method to directly assess changes in coronary size.
METHODS Thirty-two subjects were studied: 12 patients (age 55 18 years) and 20 healthy subjects (age
34  4 years). High-resolution multi-slice spiral coronary MRA (in-plane resolution of 0.52
to 0.75 mm) was performed before and after sublingual nitroglycerin (NTG). Quantitative
analysis of coronary vasodilation was performed on cross-sectional images of the right
coronary artery (RCA). A time-course analysis of coronary vasodilation was performed in a
subset of eight subjects for 30 min after NTG. Signal-to-noise ratio was also measured on the
in-plane RCA images.
RESULTS Coronary MRA demonstrated a 23% increase in cross-sectional area after NTG (16.9  7.8
mm2 to 20.8  8.9 mm2, p  0.0001), with significant vasodilation between 3 and 15 min
after NTG on time-course analysis. The MRA measurements had low interobserver
variability (5%) and good correlation with X-ray angiography (r 0.98). The magnitude of
vasodilation correlated with baseline cross-sectional area (r  0.52, p  0.03) and age (r 
0.40, p  0.019). Post-NTG images also demonstrated a 31% improvement in coronary
signal-to-noise ratio (p  0.002).
CONCLUSIONS Nitroglycerin-enhanced coronary MRA can noninvasively measure coronary artery vasodila-
tion and is a promising noninvasive technique to study coronary vasomotor function. (J Am
ublished by Elsevier Inc. doi:10.1016/j.jacc.2004.09.057Coll Cardiol 2005;45:104–10) © 2005 by the American College of Cardiology Foundation
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gmpaired coronary vasodilation, as measured by changes in
picardial coronary artery size in response to vasoactive
timuli, is an early feature of coronary atherosclerosis (1–4).
oronary endothelium-dependent vasodilation, in particular,
as been shown to predict long-term atherosclerotic disease
rogression and cardiovascular events (4–8). Impaired cor-
nary vasodilation to nitroglycerin (NTG), an endothelium-
ndependent vasodilator, has also been found in patients who
ave coronary risk factors (9) and has also been associated
ith an increased risk of future cardiac events (7). However,
revious studies have required either invasive X-ray coro-
ary angiography (XRA) (1,4–8) or intravascular ultra-
ound (10) to measure epicardial coronary vasodilator re-
ponses. A noninvasive technique for measuring human
picardial coronary vasodilation directly would allow more
idespread study of coronary vasoreactivity in patients with,
r at risk for, coronary artery disease (CAD).
Coronary magnetic resonance angiography (MRA) has
eveloped rapidly over the past decade. High-resolution
oronary MRA can now achieve sub-millimeter spatial
esolution by a variety of breath-hold and non–breath-hold
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ational Institutes of Health, American Heart Association, the Doris Duke Chari-
able Foundation, General Electric, and the Donald W. Reynolds Cardiovascular
linical Research Center at Stanford University.i
Manuscript received June 23, 2004; revised manuscript received September 16,
004, accepted September 21, 2004.echniques (11,12), making measurement of coronary vaso-
ilation feasible. It also does not require ionizing radiation
r contrast agents, making it particularly safe for serial
easurements.
This study tested the hypothesis that high-resolution
oronary MRA can quantify changes in epicardial coronary
rtery size in response to an easily administered vasodilator,
ublingual NTG, in both patients and healthy subjects.
ETHODS
ubjects. A total of 32 subjects without contraindications
o magnetic resonance imaging (MRI) were studied. This
ncluded 20 healthy subjects (age 33  5 years, 18 male/2
emale) who had no known cardiovascular disease. In
ddition, to validate the technique in patients, 12 subjects
age 53  18 years, 9 male/3 female) who had previously
ndergone XRA were also evaluated. This included six
atients with native CAD, ranging from one- to three-
essel disease, as well as six patients averaging 5  3 years
fter heart transplant (Tx). All participants provided written
nformed consent approved by the Human Subjects Com-
ittee at Stanford University.
RI. A 1.5-T Signa MRI scanner (GE Healthcare,
ilwaukee, Wisconsin) equipped with high-performance
radients (40 mT/m, 150 mT/m/ms) and a real-time
nteractive workstation was used. A commercial surface
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January 4, 2005:104–10 Coronary Vasodilation by MRAoil provided signal reception (5-inch General Purpose
oil, Model #2127316, GE Healthcare, Milwaukee,
isconsin). A real-time interactive MRI system, re-
orted previously (13,14), was used for coronary localiza-
ion (sequence parameters: 16 frames/s, recovery time
TR)  30 ms, echo time (TE)  4.6 ms, flip angle 
0°, slice thickness  7 mm, field of view  24 cm,
n-plane spatial resolution  2.7 mm).
High-resolution coronary MRA was performed using a
ulti-slice spiral sequence, as previously reported (15,16),
ith cardiac gating, breath-holding, and acquisition during
iastole (field of view  20 to 22 cm, in-plane spatial
esolution  0.52 to 0.75 mm, slice thickness  5 mm, 5
lices, TR  1 heart beat, TE  7 ms, 14 to 20 interleaves,
ip angle  60°). Images were reconstructed onto a 512 
12 matrix, yielding a pixel size of 0.39 to 0.43 mm.
tudy protocol. Vasoactive medications were discontinued
4 h before the examination. Subjects were placed supine in
he magnet with the surface coil placed over the anterior
hest. Noninvasive blood pressure and heart rate monitoring
ere performed throughout the study (Omega 1400, Invivo
esearch Inc., Orlando, Florida). Real-time interactive
RI was used to prescribe in-plane views of the right and
eft coronary arteries. For quantitative analysis, a cross-
ectional view of a linear portion of the proximal to
id-right coronary artery (RCA) was also prescribed,
voiding a site of stenosis or stent in the patients. Then,
n-plane and cross-sectional high-resolution coronary MRA
cans were acquired before and then 3 to 5 min after 0.4 mg
ublingual NTG was given to the subject while in the
agnet. For time-course analysis, we performed cross-
ectional coronary MRA in a subset of eight healthy subjects
efore and then every minute up to 5, 7, 10, 15, 20, and 30
in after sublingual NTG.
mage analysis. VASODILATION. For quantitative analysis
f coronary vasodilation, the cross-sectional RCA images
ere used. The slice with the most circular cross-section was
dentified on the pre-NTG images. The corresponding
ost-NTG slice was carefully matched according to the
urrounding cardiac and chest wall structures. These images
ere all pooled and then randomized, with no patient
nformation provided on the images. Using Scion Image
PC version of NIH Image from Scion Corporation, Fred-
Abbreviations and Acronyms
CAD coronary artery disease
MRA magnetic resonance angiography
MRI  magnetic resonance imaging
NTG nitroglycerin
RCA  right coronary artery
ROI  region of interest
SNR  signal-to-noise ratio
Tx  post-transplant
XRA  X-ray coronary angiographyrick, Maryland), all MRA images were analyzed indepen- vently by two observers, blinded to patient and NTG
nformation. Images were magnified two-fold, and a circular
egion-of-interest (ROI) tool was used to trace around the
CA, yielding cross-sectional area (Fig. 1). The pre- and
ost-NTG measurements from all 30 subjects were also
nalyzed for intraobserver and interobserver variability.
IGNAL-TO-NOISE RATIO (SNR). Because the slice thickness
f in-plane images (typically used to assess coronary anat-
my) is often on the order of the coronary diameter,
igure 1. Quantitative analysis of corresponding X-ray coronary angiog-
aphy (a) and coronary magnetic resonance angiography (MRA) (b) images
f the right coronary artery showing the quantitative measurements of
oronary size (X-ray: mean diameter 4.1 mm; MRA: cross-sectional area
19.8 mm2, diameter  5.0 mm).asodilation may be expected to increase the coronary SNR.
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Coronary Vasodilation by MRA January 4, 2005:104–10he SNR of coronary MRA before and after NTG was
ompared on in-plane RCA images using one ROI drawn
nside the coronary lumen and a second ROI drawn outside
he heart, with SNR calculated as the signal intensity of the
oronary artery divided by the standard deviation of the
rtifact-free noise.
RA CORRELATION. A subset of seven patients had XRA
erformed within one month of their MRI study. This allowed
comparison of baseline coronary diameter between XRA and
RI. Using XRA images in diastole (as the MRA acquisition
as in diastole), a 10-mm length of the RCA was analyzed by
uantitative coronary angiography (QCA plus, Sanders Data
ystems, Palo Alto, California) to calculate the mean diameter
Fig. 1); MRA diameter was calculated from the cross-
ectional area of the RCA using the formula:
lumen diameter 2[lumen area ⁄]
tatistical analysis. Data were expressed as mean values 
D. StatView (version 5, SAS Institute Inc., Cary, North
arolina) was used for all statistical analyses. The difference
n coronary size before and after NTG was compared by the
aired t test. Differences in subject groups were tested using
one-way analysis of variance (ANOVA) followed by
ost-hoc Fisher protected least significant differences test
igure 2. Right coronary artery (RCA) vasodilation with nitroglycerin (NT
howing the proximal and mid-RCA (arrows) over two slices. (Right) Cor
nd mid-vessel.PLSD). Correlation between coronary vasodilation and oaseline cross-sectional area and age was tested by non-
inear (logarithmic) regression analysis. Intra- and interob-
erver variability were analyzed by calculating both the
ercentage of the absolute difference between the two
easurements divided by the mean of the measurements as
ell as the correlation coefficient. The comparison between
RA and XRA was performed by linear regression analysis.
or time-course analysis, we performed one-way repeated-
easures ANOVA with Fisher PLSD. Statistical signifi-
ance was assumed as a two-tailed p value 0.05.
ESULTS
ll subjects completed the study without any complications.
itroglycerin caused a small but significant systemic effect.
here was a 5% decrease in systolic blood pressure (from
12  12 mm Hg to 107  8 mm Hg), 8% decrease in
iastolic blood pressure (from 72  8 mm Hg to 66  8
m Hg), and 6% increase in heart rate (from 72  18
eats/min to 77  17 beats/min). Two subjects were
xcluded from quantitative analysis—one healthy subject
ad a diminutive RCA, presumably non-dominant, whereas
ne patient had taken long-acting nitrates on the day of the
tudy.
oronary vasodilation. Coronary vasodilation was evident
eft) Coronary magnetic resonance angiography (MRA) images pre-NTG
MRA image after NTG showing clear vasodilation of both the proximalG). (Ln in-plane and through-plane coronary images of both the
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January 4, 2005:104–10 Coronary Vasodilation by MRAight and left coronary arteries (Figs. 2 to 4). On quantita-
ive analysis (n  30), coronary cross-sectional area in-
reased 23.1% (16.9  7.8 mm2 to 20.8  8.9 mm2, p 
.001) after NTG (Fig. 5). There were moderate yet
ignificant correlations between the magnitude of vasodila-
ion and the baseline cross-sectional area (r  0.52, p 
.03), and age (r  0.40, p  0.019) (Fig. 6). On subgroup
nalysis, significant vasodilation was demonstrated for both
ealthy subjects (24.0%, p  0.001) and patients (22.2%,
 0.003). However, with this endothelial-independent
asodilator, the difference in vasodilation between healthy
ubjects and patients was not significant (p  0.05 for
ubjects vs. patients and for CAD vs. Tx patients). The
igure 3. Left anterior descending coronary artery (LAD) vasodilation with
roximal LAD (arrow) before (left) and after NTG (right).
igure 4. Cross-sectional magnetic resonance angiography images of the r
NTG), showing vasodilation in a healthy volunteer (RCA area increased fr
2rom 12.6 to 15.5 mm ) (bottom). Note the multiple similarities in the shape/f
nd chest wall on the pre- and post-NTG images, indicating good spatial correoronary area measurements had an intraobserver variability
f 3  2%, with a correlation of 0.99, and an interobserver
ariability of 5  5%, with a correlation of 0.96.
ime course of coronary vasodilation. Time course anal-
sis (n  8) demonstrated significant vasodilation from
aseline to 3 min (16.9  5.9 mm2 vs. 20.8  4.6 mm2, p
0.002) with minimal change from 5 min (21.4  4.6
m2, p  0.001) to 15 min (20.5  8.1 mm2, p  0.03)
Fig. 7). The degree of vasodilation was no longer signifi-
ant at 20 and 30 min (19.3  5.0 mm2, p  0.06 and 19.3
6.5 mm2, p  0.14).
NR improvement. Clinical coronary MRA studies typi-
ally use in-plane rather than cross-sectional coronary views.
glycerin (NTG). Coronary magnetic resonance angiography images of the
oronary artery (RCA) (arrows) before (left) and after (right) nitroglycerin
2.0 to 17.0 mm2) (top) and a heart transplant patient (RCA area increasednitroight c
om 1eatures of the adjacent atrioventricular groove, right atrium and ventricle,
spondence.
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Coronary Vasodilation by MRA January 4, 2005:104–10ith NTG-induced coronary dilation, improved coronary
NR was seen on the in-plane images, increasing 31% (11.3
5.5 vs. 14.8  6.8, p  0.002).
oronary MRA vs. X-ray angiography. For the subset of
atients with recent XRA (n  7), there was good correla-
ion of baseline coronary artery diameter measurements
etween MRA and XRA (r 0.98, p 0.0001). There was
n offset in the regression line Y  1.05X  0.72 mm,
ith MRA overestimating XRA by an amount similar to
he MRA spatial resolution (0.52 to 0.75 mm).
ISCUSSION
he present study demonstrates that coronary MRA can
oninvasively detect and quantify coronary vasodilation in
oth healthy subjects and patients. Coronary cross-sectional
rea increased 23% overall, and measurements had low
nterobserver variability; NTG also increased the SNR of
oronary MRA by 31%.
oronary vasomotor function. Coronary vasodilation
lays a pivotal role in the human coronary circulation’s
igure 5. Quantitative analysis of nitroglycerin-induced coronary vasodi-
ation with coronary magnetic resonance angiography showing the signif-
cant increase in right coronary artery (RCA) cross-sectional area. Open
ircles  healthy subjects; closed triangles  patients. Filled squares and
rror bars indicate mean  SD.esponse to varying demand. Although NTG typically has teen used to demonstrate endothelium-independent vaso-
ilation as a positive control to endothelium-dependent
asodilation, some previous studies have shown that an
mpaired vasodilatory response to NTG is associated with
isk factors for CAD (9) and with an increase in future
linical events (7). However, direct measurement of epicar-
ial coronary vasodilation has typically required invasive
echniques, which limit coronary vasodilation testing to
atients already undergoing XRA and make serial or
ollow-up measurements impractical.
Several groups have used M-mode or transesophageal
chocardiography to image the left main coronary artery
17,18). However, the left main trunk is well visualized in
nly a subset of patients by transthoracic echocardiography,
nd transesophageal echocardiography is semi-invasive. A
arge number of studies have directly imaged brachial artery
asodilation by high-resolution ultrasound based on the
oncept that peripheral vascular function parallels that of
he coronary arteries because of the systemic nature of
therosclerosis (2,19,20). Although there is a reasonable
verall correlation between coronary and brachial vasomotor
unction (21,22), Hirooka et al. (23) demonstrated diver-
ent effects of L-arginine on these two vascular beds. It is,
hus, unknown if brachial vasomotor function is as predic-
ive as coronary function on an individual basis.
There are other noninvasive approaches to assess coro-
ary microvascular vasodilatory function indirectly by mea-
uring coronary flow or perfusion reserve, including
ontrast-enhanced transthoracic echocardiography (24,25),
ositron emission tomography (26), and MRI (27,28).
uture MRI studies may be able to combine measurements
f epicardial coronary vasodilation with coronary flow re-
erve.
oronary vasodilation by NTG. According to previous
eports, sublingual NTG, at a dose of 0.4 mg, typically elicits
vasodilatory response within 2 to 5 min with maximal effects
t 3 to 15 min and little residual activity by 20 to 30 min
29–31). Our time-course data were consistent with these
ublished data, demonstrating significant coronary vasodila-
ion over 3 to 15 min but not at 20 to 30 min. Whereas most
oronary vasodilation studies have used intracoronary NTG, a
tudy of sublingual NTG demonstrated an 18% increase in
ross-sectional area calculated by XRA in patients with CAD
32). Correlations between the degree of vasodilator responses
o NTG and the baseline cross-sectional area and age were also
een in our study (Fig. 6), which has been noted in previous
tudies (10,32,33). Interestingly, even in the healthy subjects,
hose with lower vasodilation (20% area change, n 7) had
higher mean age (38  2 years) compared to those with
20% area vasodilation (mean age 30  3 years, n  12).
This study included a group of different types of patients
n order to validate that coronary MRA detection of
oronary vasodilation was not limited to healthy subjects.
any coronary MRA techniques initially demonstrated in
ealthy subjects are more difficult to demonstrate in pa-
ients, due to body habitus, breath-holding ability, surgical
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January 4, 2005:104–10 Coronary Vasodilation by MRArtifacts, and the like. Although we were able to show
ignificant coronary vasodilation for the patient group,
he study was not sufficiently powered to demonstrate
ifferences between the study groups, particularly using
n endothelium-independent stimulus. The use of
ndothelium-dependent stimuli would be expected to show
reater differences between study groups, but is challenging
n the MRI environment. Typical intra-arterial agents, such
s acetylcholine, cannot safely be given systemically. Non-
harmacologic approaches, such as the cold-pressor test (4)
nd mental stress (34), offer promise and warrant further
tudy.
mproved SNR of Coronary MRA. We demonstrated
hat sublingual NTG improved coronary SNR on in-plane
maging, as an additional benefit of coronary vasodilation.
igher SNR may improve image quality, allow for higher
patial/temporal resolution, or improve visualization of
ranch vessels. Given that sublingual NTG was well-
olerated, it has the potential to improve the diagnostic
ccuracy of clinical coronary MRA studies. Of note, long-
cting nitrates were used as part of the first multicenter
linical coronary MRA trial (35).
tudy limitations. As mentioned, a major limitation to the
urrent study is that we assessed only endothelium-
igure 6. Non-linear (logarithmic) correlations of coronary vasodilator
esponse to baseline cross-sectional area (a), and patient age (b). Circles 
ealthy subjects; triangles patients. NTG nitroglycerin; RCA right
oronary artery.ndependent coronary vasodilation using NTG, as
v
tndothelium-dependent coronary stimuli have practical
imitations and the primary goal was to demonstrate that
oronary MRA can quantitate coronary vasodilation in both
ealthy subjects and patients. A substantially larger clinical
tudy would be needed in order to be sufficiently powered to
how significant differences in coronary vasodilation be-
ween study groups.
Quantitative analysis was performed exclusively on the
CA because it has the highest SNR, allowing higher
patial resolution for more precise quantification; RCA
easurements by MRA have also been shown to be very
eproducible (36). Further improvements in coronary MRA
hould allow quantitative analysis of both the RCA and left
oronary system.
The XRA data were limited to the subset of patients who
ad a recent angiogram and provides only baseline data (not
re-/post-NTG). The data are consistent with previous
tudies showing both good correlation between coronary
RA and XRA, as well as the overestimation by MRA
37–39). The amount of overestimation by MRA is due to
artial volume effects related to the spatial resolution of the
maging sequence, the pixel width of the image, as well as
he window/level settings of the image and how the ROI is
laced (37). Improvements in spatial resolution and quan-
itative image analysis software may help to minimize this
verestimation (36,37). The time between XRA and MRA
tudies and that holding vasoactive medications for 24 h was
ot part of the instructions before XRA may have further
ontributed to differences between the XRA and MRA
easurements.
linical implications. Coronary vasodilation by MRA
ay have clinical applications in addition to the potential
or improved SNR and image quality of clinical coronary
RA studies. A noninvasive method to assess coronary
asodilation avoids the small, but non-zero risk of XRA.
oronary MRA could, thus, be used to assess vasodilatory
rugs, as well as to assess serial changes of coronary function
n response to therapeutic interventions. To be most useful,
n endothelium-dependent stimulus needs to be incorpo-
ated. Moreover, combining coronary vasodilation with MR
echniques for the study of coronary anatomy, coronary
igure 7. Time course of coronary vasodilation. Significant coronary
asodilation was seen starting at 3 min after nitroglycerin and persisting up
o 15 min. RCA  right coronary artery.
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Coronary Vasodilation by MRA January 4, 2005:104–10ow, and the coronary wall may provide a comprehensive
oninvasive structural and functional evaluation of CAD.
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